Post-vaccination antibodies against SARS-CoV-2: Correspondence
Dear Editor, we would like to share ideas on the publication “Post-vaccination antibodies against SARS-CoV-2 in a cohort of workers of a general hospital”(1). In the cohort and with fresh SARS-CoV-2 infections, Sabater Vidal et al. noticed a general decrease in IgG-S and IgG-NP antibodies following...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Catalan |
| Published: |
Associació Catalana de Salut Laboral
2022-12-01
|
| Series: | Archivos de Prevención de Riesgos Laborales |
| Online Access: | https://archivosdeprevencion.eu/index.php/aprl/article/view/268 |
| Summary: | Dear Editor, we would like to share ideas on the publication “Post-vaccination antibodies against SARS-CoV-2 in a cohort of workers of a general hospital”(1). In the cohort and with fresh SARS-CoV-2 infections, Sabater Vidal et al. noticed a general decrease in IgG-S and IgG-NP antibodies following the second dosage of the Pfizer-BioNTech vaccine (1). Additionally, Sabater Vidal et al. advocated booster shots, continuing preventative measures, and further research to determine the vaccine's protection threshold(1). We concur that the COVID-19 can boost resistance in research subjects. Recognizing the impact of earlier asymptomatic COVID-19 is crucial, though. Asymptomatic COVID-19 is not unusual, and anyone can have had it in the past(2). It is important to take into account any potential confounding effects from earlier asymptomatic COVID-19 when interpreting the vaccination's effects.
|
|---|---|
| ISSN: | 1138-9672 1578-2549 |